Aminoglycoside-induced nephrotoxicity--a focus on monitoring: a review of literature (Q38239999)

31 August 2017

title

Aminoglycoside-induced nephrotoxicity--a focus on monitoring: a review of literature (English)

1 reference

31 August 2017

Christopher J Destache

series ordinal

1

0 references

publication date

14 August 2014

1 reference

Journal of Pharmacy Practice

31 August 2017

published in

1 reference

31 August 2017

volume

27

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

562-566

1 reference

Do we still need the aminoglycosides?

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Back to the future: using aminoglycosides again and how to dose them optimally

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Individualizing Gentamicin Dosage Regimens in Burn Patients with Gram-Negative Septicemia: A Cost–Benefit Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Why Monitor Serum Levels of Gentamicin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Gentamicin blood levels: a guide to nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Once-daily dosing of aminoglycosides: review and recommendations for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Extended-interval aminoglycoside administration for children: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Glomerular nephrotoxicity of aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Autoradiography of gentamicin uptake by the rat proximal tubule cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Megalin Deficiency Offers Protection from Renal Aminoglycoside Accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Pharmacokinetic dosing of aminoglycosides: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Single or multiple daily doses of aminoglycosides: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Once-daily dosing of aminoglycoside antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Therapeutic drug monitoring of tobramycin: once-daily versus twice-daily dosage schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Acute renal failure associated with inhaled tobramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

Ampicillin Plus Ceftriaxone Is as Effective as Ampicillin Plus Gentamicin for TreatingEnterococcus faecalisInfective Endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0897190014546102

21 January 2018

Identifiers

DOI

10.1177/0897190014546102

1 reference

31 August 2017

1 reference